In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
Renowned prostate cancer researcher Folakemi T. Odedina, PhD, took the stage at the AACR Conference on the Science of...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
In an innovative new initiative to drive progress against cancer, the American Association for Cancer Research (AACR) has announced...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...